ABSTRACT
From the beginning of the HIV epidemic, as epitomized by the early US label of 'GRID' or Gay Related Immune Deficiency, views of the disease's impact have been refracted through a male-orientated prism. Recently, however, there has been increased attention to women's biological, social, epidemiological and economic vulnerabilities to the effects of the virus, in recognition of the fact that from a worldwide standpoint (and increasingly in the US) this is very much a woman's disease. The consequences of these vulnerabilities for the care of women with HIV, however, have not yet been well studied, and we therefore do not know enough about how care models should be organized to respond to these needs.
